title: Caspase activity is not required for the mitotic checkpoint or mitotic slippage in human cells.
abstract: Biochemical studies suggest that caspase activity is required for a functional mitotic checkpoint (MC) and mitotic slippage. To test this directly, we followed nontransformed human telomerase immortalized human retinal pigment epithelia (RPE-1) cells through mitosis after inhibiting or depleting selected caspases. We found that inhibiting caspases individually, in combination, or in toto did not affect the duration or fidelity of mitosis in otherwise untreated cells. When satisfaction of the MC was prevented with 500 nM nocodazole or 2.5 μM dimethylenastron (an Eg5 inhibitor), 92-100% of RPE-1 cells slipped from mitosis in the presence of pan-caspase inhibitors or after simultaneously depleting caspase-3 and -9, and they did so with the same kinetics (~21-22 h) as after treatment with nocodazole or Eg5 inhibitors alone. Surprisingly, inhibiting or depleting caspase-9 alone doubled the number of nocodazole-treated, but not Eg5-inhibited, cells that died in mitosis. In addition, inhibiting or depleting caspase-9 and -3 together accelerated the rate of slippage ~40% (to ~13-15 h). Finally, nocodazole-treated cells that recently slipped through mitosis in the presence or absence of pan-caspase inhibitors contained numerous BubR1 foci in their nuclei. From these data, we conclude that caspase activity is not required for a functional MC or for mitotic slippage.
authors: Division of Translational Medicine, Biggs Laboratory, Wadsworth Center, New York State Department of Health, Albany, NY 12201-0509, USA.
authors: Kyunghee
authors: K
authors: Lee
authors: Alison E
authors: AE
authors: Kenny
authors: Conly L
authors: CL
authors: Rieder
references: Mol Cell Biol. 2007 Jan;27(2):689-98
references: 17101792
references: EMBO J. 2010 Jul 21;29(14):2407-20
references: 20526282
references: Cancer Res. 2008 Aug 1;68(15):6181-9
references: 18676841
references: Oncol Res. 2005;15(3):161-8
references: 16050137
references: PLoS One. 2010 Dec 21;5(12):e15724
references: 21203573
references: Nature. 1996 Nov 28;384(6607):368-72
references: 8934524
references: Mol Cell Biol. 2005 Nov;25(21):9232-48
references: 16227576
references: Cell Death Differ. 2007 Feb;14(2):387-91
references: 17008913
references: Mol Cell. 2007 Apr 27;26(2):301-10
references: 17466630
references: J Biol Chem. 2007 Feb 9;282(6):3672-9
references: 17158872
references: Cell Motil Cytoskeleton. 2009 Aug;66(8):437-47
references: 18792104
references: Mol Cell Biol. 2010 Dec;30(24):5726-40
references: 20937773
references: Mol Cell Biol. 2010 Feb;30(3):640-56
references: 19917720
references: Cancer Res. 2010 Aug 1;70(15):6325-35
references: 20647325
references: Nat Cell Biol. 2009 Nov;11(11):1363-9
references: 19820702
references: EMBO J. 2009 Oct 21;28(20):3216-27
references: 19730412
references: Methods. 2006 Jan;38(1):2-16
references: 16343936
references: Biochem Biophys Res Commun. 2009 Oct 16;388(2):366-71
references: 19665996
references: Proteomics. 2008 Jan;8(2):289-300
references: 18186019
references: Apoptosis. 2006 May;11(5):765-71
references: 16532268
references: Clin Cancer Res. 2008 Aug 15;14(16):5000-5
references: 18698017
references: Cancer Cell. 2003 Dec;4(6):483-97
references: 14706340
references: Nature. 1998 Dec 10;396(6711):580-4
references: 9859993
references: Cancer Res. 2008 May 1;68(9):3269-76
references: 18451153
references: Nat Med. 2000 Nov;6(11):1241-7
references: 11062535
references: Apoptosis. 2003 Aug;8(4):345-52
references: 12815277
references: Biochem J. 2002 Aug 1;365(Pt 3):765-72
references: 11978176
references: Oncogene. 2009 Apr 16;28(15):1748-58
references: 19270727
references: J Biol Chem. 2005 Aug 26;280(34):30263-72
references: 15994297
references: Trends Biochem Sci. 2011 Mar;36(3):141-50
references: 20888775
references: J Biol Chem. 2009 Aug 14;284(33):21777-21781
references: 19473994
references: Curr Biol. 2006 Jun 20;16(12):1194-200
references: 16782009
references: Cancer Res. 2007 Jan 1;67(1):237-45
references: 17210704
references: J Cell Biol. 2008 Aug 25;182(4):623-9
references: 18710927
references: Mol Cell Biol. 1998 Feb;18(2):1055-64
references: 9448003
references: Cancer Cell. 2008 Aug 12;14(2):111-22
references: 18656424
references: Breast Cancer Res Treat. 2009 Sep;117(1):219-21
references: 18853248
references: Science. 2006 Feb 10;311(5762):847-51
references: 16469926
references: Cell Cycle. 2010 May;9(9):1792-801
references: 20436289
references: Curr Opin Cell Biol. 2009 Dec;21(6):871-7
references: 19822411
references: Chembiochem. 2005 Jul;6(7):1173-7
references: 15912555
references: Dev Cell. 2004 Nov;7(5):637-51
references: 15525526
references: Cancer Res. 2008 May 1;68(9):3440-9
references: 18451172
references: FEBS J. 2010 Aug;277(16):3437-48
references: 20646066
references: Invest Ophthalmol Vis Sci. 2002 May;43(5):1622-30
references: 11980883
references: Genes Cells. 2008 Jun;13(6):609-21
references: 18459962
references: Cell Death Differ. 2005 Jul;12(7):827-30
references: 15818396
references: Mol Biol Cell. 2010 Jul 1;21(13):2150-60
references: 20462950
references: Apoptosis. 2000 Feb;5(1):29-36
references: 11227488
references: Biochem J. 2004 Dec 1;384(Pt 2):201-32
references: 15450003
references: J Cell Biol. 2000 Sep 4;150(5):975-88
references: 10973989
references: EMBO Rep. 2006 Oct;7(10):988-94
references: 17016456